Current european regulatory perspectives on insulin analogues

Insulin analogues are increasingly considered as an alternative to human insulin in the therapy of diabetes mellitus. Insulin analogues (IAs) are chemically different from human insulin and may have different pharmacokinetic or pharmacodynamic properties. The significance of the modifications of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Enzmann, Harald G, Weise, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224552/
https://www.ncbi.nlm.nih.gov/pubmed/21736748
http://dx.doi.org/10.1186/1758-5996-3-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224552/
https://www.ncbi.nlm.nih.gov/pubmed/21736748
http://dx.doi.org/10.1186/1758-5996-3-14

Ejemplares similares